LSIPR 50 2018: Brian Anderson


Brian Anderson was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.


Name: Brian Anderson

Organisation: Oxford Nanopore Technologies

LSIPR 50 2018, Brian Anderson, Allergan, Teva, Abbreviated New Drug Applications, Saint Regis Mohawk Tribe, Restasis, Hatch-Waxman Act, IP litigation